Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
Antivascular endothelial growth factor (VEGF) treatment is still used intravitreally worldwide for various neovascular diseases, despite other available, approved treatments. We performed a systematic search of the literature focused on visual physiology studies. We used the online biomedical search...
Main Authors: | In Hwan Hong, Sung Pyo Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=7;spage=559;epage=568;aulast=Hong |
Similar Items
-
Antivascular endothelial growth factor in treatment of choroidal osteoma not associated with choroidal neovascular membrane
by: Thomas Cherian, et al.
Published: (2017-01-01) -
Intravitreal antivascular endothelial growth factors for retinopathy of prematurity in Ibadan: Method of administration
by: Yewande Olubunmi Babalola, et al.
Published: (2020-01-01) -
Combined argon laser photocoagulation and antivascular endothelial growth factor for management of macular polypoidal choroidal vasculopathy
by: Parveen Sen, et al.
Published: (2016-01-01) -
Risk of Thromboembolic Events and Major Adverse Cardiovascular Events Following Antivascular Endothelial Growth Factor Therapy in Patients with Colorectal Cancer
by: Yen-Cheng Chen, et al.
Published: (2022-12-01) -
Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
by: Yu-Yen Chen, et al.
Published: (2019-12-01)